| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 11 |
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
|
| Nov 7 |
TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
|
| Oct 31 |
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
|
| Oct 29 |
TriSalus Life Sciences files to sell 10.59M shares of common stock for holders
|
| Oct 14 |
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Sep 23 |
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
|
| Sep 14 |
TriSalus Life Sciences Inc (TLSI) CEO Buys Shares
|
| Aug 1 |
TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
|
| Jul 1 |
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
|
